3-year prevalence of alcohol-related disorders in German patients treated with high-potency opioids

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 10, 2012, Pages 1125-1129

  Jobski, Kathrin ^a   Schmid, Ulrike ^a   Behr, Sigrid ^a   Andersohn, Frank ^b   Garbe, Edeltraut ^a  

^a LEIBNIZ INSTITUTE FOR PREVENTION RESEARCH AND EPIDEMIOLOGY BIPS   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Alcohol Related Disorders; German Pharmacoepidemiological Research Database; Opioid Use; Pharmacoepidemiology

Indexed keywords

BUPRENORPHINE; FENTANYL; LEVOMETHADONE; MORPHINE; NALOXONE PLUS OXYCODONE; OPIATE DERIVATIVE; OXYCODONE; PIRITRAMIDE;

ADULT; AGE; AGED; ALCOHOLISM; ARTICLE; CONTROLLED DRUG RELEASE; DRUG POTENCY; FEMALE; GERMANY; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; SEX;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL-RELATED DISORDERS; ANALGESICS, OPIOID; DATABASES, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PAIN; PREVALENCE;

EID: 84867141904     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3268     Document Type: Article

References (16)

1. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009; 10: 113-130.
2. Dhalla IA, Persaud N, Juurlink DN. Facing up to the prescription opioid crisis. BMJ 2011; 343: d5142-
3. Pergolizzi J, Boger RH, Budd K, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 2008; 8: 287-313. DOI: 10.1111/j.1533-2500.2008.00204.x
4. Wu LT, Woody GE, Yang C, et al. Subtypes of nonmedical opioid users: results from the national epidemiologic survey on alcohol and related conditions. Drug Alcohol Depend 2010; 112: 69-80.
5. Weathermon R, Crabb DW. Alcohol and medication interactions. Alcohol Res Health 1999; 23: 40-54.
6. Questions and answers on the review of modified-release oral opioid medicines of the WHO level III scale for the management of pain - Outcome of a procedure under Article 31 of Directive 2001/83/EC as amended, 19 October 2010 available at http://http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Modified-released_oral_opioids_31/WC500099180.pdf (accessed April 24, 2011). 2010;
7. FDA Asks Purdue Pharma to Withdraw Palladone for Safety Reasons, available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2005/ucm108460.htm (accessed March 12, 2010). FDA NEWS RELEASE 2005;
8. Schink T, Behr S, Garbe E. Externe Validierung von Verschreibungsdaten nichtsteroidaler Antirheumatika anhand des Arzneiverordnungs-Reports. 2009; 54. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (gmds). (9 September 2009)
9. Pigeot I, Ahrens W. Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations. Pharmacoepidemiol Drug Saf 2008; 17: 215-223. DOI: 10.1002/pds.1545
10. Brennan PL, Schutte KK, Moos RH. Pain and use of alcohol to manage pain: prevalence and 3-year outcomes among older problem and non-problem drinkers. Addiction 2005; 100: 777-786. DOI: 10.1111/j.1360-0443.2005.01074.x
11. Schepis TS, Hakes JK. Non-medical prescription use increases the risk for the onset and recurrence of psychopathology: results from the National Epidemiological Survey on Alcohol and Related Conditions. Addiction 2011; 106: 2146-2155.
12. Ryder N, Cullen W, Barry J, et al. Prevalence of problem alcohol use among patients attending primary care for methadone treatment. BMC Fam Pract 2009; 10: 42- DOI: 10.1186/1471-2296-10-42
13. Smith MY, Palmer L, Margolis J, et al. Prevalence and costs of concomitant use of alcohol in medicaid patients dispensed opioid analgesics for chronic pain. Pharmacoepidemiol Drug Saf 2007; 16: S80-S81.
14. Saffier K, Colombo C, Brown D, et al. Addiction Severity Index in a chronic pain sample receiving opioid therapy. J Subst Abuse Treat 2007; 33: 303-311. DOI: 10.1016/j.jsat.2006.12.011
15. Pabst A, Kraus L. Alcohol consumption, alcohol-use disorders and trends. Results of the 2006 Epidemiological Survey of Substance Abuse. Sucht 2008; 54: 36-46.
16. Culverhouse R, Bucholz KK, Crowe RR, et al. Long-term stability of alcohol and other substance dependence diagnoses and habitual smoking: an evaluation after 5 years. Arch Gen Psychiatry 2005; 62: 753-760.